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Abstract
Background: Influenza vaccination policy for elderly people in Britain has changed twice since
1997 to increase protection against influenza but there is no information available on how this has
affected vaccine uptake, and socioeconomic variation therein, among people aged over 74 years.
Methods: Vaccination information for 1997–2000 was collected directly from general practices
taking part in a MRC-funded Trial of the Assessment and Management of Older People in the
Community. This was linked to information collected during assessments carried out as part of the
Trial. Regression modelling was used to assess relative probabilities (as relative risks, RR) of having
vaccination according to year, gender, age, area and individual socioeconomic characteristics.
Results: Out of 106 potential practices, 73 provided sufficient information to be included in the
analysis. Uptake was 48% (95% CI 45%, 55%) in 1997 and did not increase substantially until 2000
when the uptake was a third higher at 63% (50%, 66%). Vaccination uptake was lower among
women than men (RR 0.9), people aged 85 or more compared to people aged under 80 (RR 0.9),
those in the most deprived areas (RR 0.8) compared to the least deprived, and was relatively high
for those in owner-occupied homes with central heating compared to other non-supported
housing (RR for remainder = 0.9). This pattern did not change over the years studied.
Conclusions: Increased uptake in 2000 may have resulted from the additional financial resources
given to practices; it was not at the expense of more disadvantaged socioeconomic groups but nor
did they benefit disproportionately.
Background
Influenza can have a dramatic impact on morbidity and
mortality. Routine influenza vaccination is protective
against illness [1], acute respiratory hospitalisations and
deaths [2]. The Department of Health recommended rou-
tine administration of the influenza vaccine to all aged
over 74 years in 1998 and in 2000 extended this to all
aged over 64 years while adding an item-of-service pay-
ment [3]. The GPs were allocated extra funds for the pur-
poses of identifying and communicating individually
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with those eligible, monitoring progress of the vaccina-
tion campaign, and helping practices with insufficient
staff. Financial incentives for interventions have been pro-
posed as a factor for successfully translating other evi-
dence into practice [4] and trials randomising US primary
care physicians confirm this for influenza vaccination. In
the US healthcare setting an offer of up to $1.60 per vac-
cine produced a 7% increase in immunisation rates in
patients aged over 64 years [5,6] and in the UK target per-
formance-related bonuses have been effective for other
preventive practice [4].
In 2000 65% of over-64 year olds in Britain were vacci-
nated against influenza [7]. We are not aware of any pro-
spective studies specifically designed to evaluate how
change in policy was changing the patterns of uptake by
socioeconomic factors in Britain. This is of interest in the
light of the Government Policy to tackle health inequali-
ties [8]. The MRC Trial of Assessment and Management of
Older People in the Community (MRC Study) provided
the opportunity to evaluate these changes in vaccination
policy retrospectively in terms of overall uptake and vari-
ation by socioeconomic status in the more vulnerable
over-74 year olds during the period 1997–2000.
Methods
Assessments for the MRC Study, described elsewhere [9],
took place between 1995 and 1999 in 106 general prac-
tices that belonged to the General Practice Research
Framework. They were spread throughout Great Britain
and the selection was stratified by practice-level tertiles of
Jarman score and Standardised Mortality Ratio. For any
one practice the assessments were spread over one year
but the practices were recruited in phases during this
period. In May 2000 these practices were asked to provide
data on individuals' vaccination status in each year from
the year they joined the Study to 1999. They were
approached again in 2001 to provide data for the winter
2000 season. They were asked to use their own records for
the data.
Seventy-three practices provided useable data on vaccina-
tions: 55 supplied data for each of 1997–2000 winter sea-
sons (September-February), 11 for 1997–1999, and seven
for 2000 only. Their characteristics are given in Table 1: 28
practices provided the data direct from their electronic
records and 44 practices extracted the data manually from
their records (one not known). Eleven other practices
were excluded because not able to provide information on
past vaccination status for people who had since died.
Postcode linkage gave the area Carstairs deprivation score
[10] and population density for the Enumeration District
of patient's residence. One of the trial interventions com-
pared giving a detailed as well as a brief assessment to eve-
ryone (universal arm) with giving a detailed assessment
only to those whose brief assessments fulfilled pre-speci-
fied criteria of need for further investigation (targeted
arm).
The Trial included people aged over 74 years in the year
the practice undertook the trial intervention; it excluded
people in long-term nursing care or with terminal illness.
Additional inclusion criteria for the vaccination analysis
in any year were being alive on 30 November and still reg-
istered with the Trial practice.
Analysis strategy
The analyses are confined to those for whom vaccination
records were available in the practices that provided infor-
mation. Trends were confined to 1997–2000 since rela-
tively few practices were participating before this time.
Generalised estimating equations based on Poisson
regression with robust standard errors were used – this is
an alternative to logistic regression and enables direct esti-
mation of risk ratios. Modelling took into account cluster-
ing within practice and person by adjusting for intra-
cluster correlations in using robust standard errors at the
practice level. The software package Stata 7 was used [11].
First, analyses of uptake by year were carried out only
adjusting for age and gender, using information from all
73 practices (Model 1). Then these were adjusted for the
deprivation and urbanisation levels of enumeration dis-
tricts in which people lived (Model 2). Analyses with both
individual and area level socio-economic factors were
Table 1: Characteristics of practices by years took part in the 
vaccination study
Years provided vaccination records used in 
analyses
1997–1999 2000 1997–2000 None
Jarman tertile
Low 3 3 16 13
Med 7 2 16 8
High 1 2 23 12
SMR tertile
Low 2 2 18 10
Med 3 2 19 11
High 6 3 18 12
List size
<5000 3 0 20 10
5000 or more 8 7 35 23
Number of GPs
<7 10 6 51 31
7 or more 1 1 4 2
11 7 55 33
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confined to the 42 practices in the universal arm where all
subjects had detailed assessments. Before adding in these
socioeconomic factors (Models 4 and 5) the analysis by
year adjusted for gender and age was repeated on the uni-
versal arm subset (Model 3) so that any differences in
trends in this subset compared to the full sample could be
seen. To assess whether variation by socioeconomic fac-
tors had changed over time, Wald tests were carried out for
statistical significance of interactions between year and
each of the socioeconomic and urbanisation measures in
turn.
The analyses presented took advantage of the larger sam-
ple size from including everyone in the relevant practices
with a vaccination record. To exclude the possibility that
the yearly uptake figures might be distorted by changes in
practices and people included in the figures, analyses were
also run on the subgroup who had records for all four
years.
Results
There were 42057 people eligible for the trial in all 106
practices, 28492 in the 72 practices participating, of
whom 24654 (87%) people had vaccination records for at
least one year. This may underestimate success rate in
obtaining information since some of those who were eli-
gible for the trial may no longer have been in the practice
for the vaccine follow-up period; information was not suf-
ficiently complete for non-responders to the Trial to calcu-
late the exact numbers left in the practice. Postcode
linkage was missing for 3079 (12%) leaving 21575 for
analysis; 51% of these, (10951) had information for all
years (the 4-year subsample). The characteristics of the
sample in each year are given in Tables 2 (73-practice sam-
ple) and 3 (42-practice sample). The sample in successive
years aged as expected. Composition by gender, Carstairs
deprivation index and urban indicator changed little in
successive years. The only consistent difference between
the 73-practice and 42-practice samples, other than size,
were a smaller percentage living in the most deprived
areas in the latter. The people that were in the sample for
all four years were younger than the total sample available
in 1997. The gender age composition of the two subsam-
ples in 1997 was also very similar to that of the 42057
people eligible for the trial (not shown).
Table 2: Characteristics of sample for whom vaccination data available, by year: all practices
1997 n = 18162 63 
practices1
1998 n = 17962 66 
practices2
1999 n = 16254 66 
practices
2000 n = 13762 62 
practices3
In all years n = 
10951 53 practices 
Age in 1997
No % No % No % No % No %
Male 6457 35.6 6339 35.3 5687 35.0 4797 34.8 3778 34.5
< 80 yrs 2773 15.3 2376 13.2 1612 9.9 672 5.1 1873 17.1
80–84 yrs 2231 12.3 2349 13.1 2377 14.6 2535 18.0 1298 11.9
>= 85 yrs 1453 8.0 1614 9.0 1698 10.4 1588 11.5 607 5.5
Median age (80) (81) (82) (82) (80)
Female 14551 64.4 11623 64.7 10567 65.0 8967 65.2 7173 65.5
<80 yrs 4139 22.8 3503 19.5 2387 14.7 1015 7.4 2954 27.0
80–84 yrs 4041 22.2 4156 23.1 4089 25.2 4106 29.8 2517 23.0
>=85 yrs 3525 19.4 3964 22.1 4091 25.2 3846 28.0 1702 15.5
Median age (82) (82) (83) (84) (81)
Deprivation quintile4
Least deprived                      4567 25.2 4689 26.1 4287 26.4 3419 24.8 2587 23.6
2nd quintile 5479 30.2 5420 30.2 4933 30.4 3963 28.8 3290 30.0
3rd quintile 3822 21.0 3694 20.6 3336 20.5 3037 22.1 2399 21.9
4th quintile 2444 13.5 2432 13.5 2182 13.4 2000 14.5 1518 13.9
Most deprived 1850 10.2 1727 9.6 1516 9.3 1343 9.8 1157 10.6
Population density5
<250 pers km-2 6156 33.9 6116 34.0 5539 34.1 4509 32.8 3931 35.9
250–1000 pers km-2 4472 24.6 4336 24.1 3913 24.1 3652 26.5 2691 24.5
1000–2500 pers km-2 5074 27.9 4966 27.6 4511 27.8 3549 25.8 2602 23.8
>=2500 pers km-2 2460 13.5 2544 14.2 2291 14.1 2052 14.9 1727 15.8
1. 53 practices in all years plus 10 practices in years 1997–1999 2. 53 practices in all years plus 11 practices in years 1997–1999 plus 2 practices in 
1998–2000 3. 53 practices in all years plus 7 practices in 2000 only plus 2 practices in 1998–2000 4. Quintiles defined according to distribution of 
Enumeration Districts in Britain 5. Population density smoothed over a 5-kilometre radius from the centroid of the Enumeration District
BMC Family Practice 2004, 5 http://www.biomedcentral.com/1471-2296/5/8
Page 4 of 6
(page number not for citation purposes)
In successive years 1997 to 2000 48% (95% CI 45–55%),
50% (47–54%), 51% (49–55%) and 63% (60–66%) were
vaccinated. The pattern was replicated among gender-age
sub-groups and among the 4-year subsample. Adjusted
for gender and age the proportional increase in vaccina-
tion uptake in 2000 compared to 1997 was 32% (95% CI
25–41%) and small but statistically significant in interim
years (Table 4 Model 1). The 4-year subsample produced
very similar results (not shown). Additionally in this sub-
sample, whereas only 10% of those unvaccinated in
1997–8 were vaccinated in 1999, 28% of those unvacci-
nated in 1997–9 were vaccinated in 2000.
Coverage was lower among women and people aged 85
years or over (Model 1) and for those in the most deprived
quintile of Carstairs (Model 2). In the subset with infor-
mation on individual socioeconomic position uptake was
similar among people in owner-occupied accommoda-
tion with central heating and those in sheltered or resi-
dential homes, but 6% lower among others (Model 4).
The difference in uptake by area deprivation was statisti-
cally significant in this subset before adjustment for indi-
vidual socioeconomic position (Model 4), but not
afterwards (Model 5). Part of the shortfall in uptake in the
most deprived areas was accounted for by the individual
position. Although variation by population density was
not statistically significant there is some indication of
higher uptake in urban areas in this group of practices.
There were no significant interactions between year and
any of area deprivation, population density, individual
socioeconomic position, or gender.
Discussion
Compared with 1997, vaccination uptake increased
noticeably in 2000, coinciding with greater emphasis on
meeting targets, but not in 1998 when policy changed to
routine vaccination for everyone aged over 74 years. As
our sample only covers those aged 75 years and over, it is
Table 3: Characteristics of sample for whom vaccination data available, by year: practices with individual socioeconomic information
1997 n = 8334 37 
practices1
1998 n = 7944 38 
practices2
1999 n = 7294 38 
practices
2000 n = 6159 34 
practices3
In all years n = 
5130 29 practices
No % No % No % No % No %
Male 3170 38.0 3026 38.1 2753 37.7 5498 34.7 1938 37.8
< 80 yrs 1378 16.5 1116 14.0 735 10.0 815 5.1 948 18.5
80–84 yrs 1105 13.3 1135 14.3 1184 16.2 2857 18.0 677 13.2
>= 85 yrs 687 8.2 775 9.8 834 11.4 5498 11.5 313 6.1
Median age (80) (81) (82) (82) (80)
Female 5164 62.0 4918 61.9 4541 62.3 1035 65.3 3192 62.2
<80 yrs 1873 22.5 1509 19.0 1030 14.2 6 7.9 1354 26.4
80–84 yrs 1775 21.3 1760 22.2 1794 24.6 1259 29.7 1109 21.6
>=85 yrs 1516 18.2 1649 20.8 1717 23.5 4711 27.7 729 14.2
Median age (81) (82) (83) (83) (81)
Deprivation quintile4
Least deprived                      2247 27.0 2206 27.8 2060 28.2 1811 29.4 1429 27.9
2nd quintile 2412 28.9 2269 28.6 2076 28.5 1768 28.7 1468 28.6
3rd quintile 1831 22.0 1767 22.2 1620 22.2 1380 22.4 1155 22.5
4th quintile 1203 14.4 1128 14.2 1025 14.1 790 12.8 708 13.8
Most deprived 641 7.7 574 7.2 513 7.0 410 6.7 370 7.2
Population density5
<250 pers km-2 2578 30.9 2363 29.8 2164 29.7 1944 31.6 1778 34.7
250–1000 pers km-2 2168 26.0 2071 26.1 1905 26.1 1610 26.1 1240 24.2
1000–2500 pers km-2 2382 28.6 2250 28.3 2085 28.6 1591 25.8 1259 24.5
>=2500 pers km-2 1206 14.5 1260 15.9 1140 15.6 1014 16.5 853 16.6
Socioeconomic status6
Owner & c heating 4896 58.8 4737 59.6 4440 60.9 3893 63.2 3225 62.9
without c heating 784 9.4 738 9.3 675 9.2 575 9.3 484 9.4
Renter & c heating 1648 19.8 1557 19.6 1378 18.9 1104 17.9 908 17.7
without c heating 356 4.3 322 4.1 287 3.9 197 3.2 181 3.5
Supported housing 650 7.8 590 7.4 514 7.1 390 6.3 332 6.5
1. 29 practices in all years plus 8 practices in years 1997–1999 2. 29 practices in all years plus 8 practices in years 1997–1999 plus 1 practice in 
1998–2000 3. 29 practices in all years plus 4 practices in 2000 only plus 1 practice in 1998–2000 4. Quintiles defined according to distribution of 
Enumeration Districts in Britain 5. Population density smoothed over a 5-kilometre radius from the centroid of the Enumeration District 6. C 
heating = central heating. Supported accommodation includes sheltered housing and residential homes
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assumed that the financial incentives and resources
applied to practices played a greater part in the upturn
than the extension of the policy to all aged 65 years and
over. In 2000 the target of 60% coverage in over-64 year
olds was exceeded in our sample of over-74 year olds. The
modest socioeconomic differentials in influenza vaccine
uptake were also unchanged over time (no significant
interactions), i.e. the increased uptake was not at the
expense of the less well-off groups but nor did it benefit
them disproportionately. It appears that the extra effort in
2000 did not target by socioeconomic or gender or age-
group (e.g. over 80s compared to under 80s). The effort
may have been in terms of increasing attention to those
not considered of the highest risk. Possibly indicative of
this, the relative risk for being vaccinated for people
reporting a respiratory problem at assessment compared
with those who did not was 1.15 (95% CI 1.09–1.22) in
1997 and 1.06 (95% CI 1.03–1.09) in 2000. Equivalent
figures for a CVD history were 1.10 (1.05, 1.15) in 1997
and 1.04 (1.00, 1.07) in 2000. However, this evidence
should be treated cautiously since we only have health sta-
tus at the time of assessment so that by 2000 it may have
been out of date. Improved recording might account for
some of the observed increase in 2000.
Table 4: Modelling effect of year and socioeconomic factors on vaccination uptake: risk ratios (95% confidence intervals)
Categories Model 11 73 
practices n = 66140 
records3
Model 21 73 
practices n = 66140 
records3
Model 31 42 
practices2 n = 29731 
records3
Model 41 42 
practices2 n = 29731 
records3
Model 51 42 
practices2 n = 29731 
records3
Year
1997 1.00 1.00 1.00 1.00 1.00
1998 1.06 (1.02,1.09) 1.05 (1.02,1.09) 1.08 (1.03,1.13) 1.07 (1.03,1.12) 1.08 (1.03,1.13)
1999 1.09 (1.05,1.14) 1.09 (1.05,1.14) 1.10 (1.04,1.16) 1.09 (1.03,1.16) 1.09 (1.04,1.15)
2000 1.33 (1.25,1.42) 1.33 (1.25,1.42) 1.32 (1.22,1.43) 1.32 (1.22,1.42) 1.32 (1.22,1.42)
p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001
Gender
Male 1.00 1.00 1.00 1.00 1.00
Female 0.89 (0.87,0.91) 0.89 (0.87,0.91) 0.89 (0.87,0.92) 0.88 (0.86,0.91) 0.90 (0.87,0.92)
p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001
Current age (years)
Under 80 1.00 1.00 1.00 1.00 1.00
80–84 1.01 (0.98,1.04) 1.01 (0.98,1.04) 1.01 (0.97,1.05) 1.02 (0.98,1.07) 1.02 (0.98,1.06)
85 or more 0.92 (0.88,0.96) 0.92 (0.88,0.96) 0.89 (0.83,0.94) 0.91 (0.85,0.96) 0.89 (0.84,0.94)
p < 0.001 p < 0.001 p < 0.001 p < 0.001 p < 0.001
Carstairs quintiles (deprivation)
Least Not in model 1.00 Not in model 1.00 1.00
Second 1.00 (0.95,1.05) 1.04 (0.97,1.12) 1.05 (0.97,1.13)
Mid 0.98 (0.92,1.05) 1.01 (0.93,1.10) 1.03 (0.94,1.13)
Fourth 0.95 (0.84,1.08) 0.98 (0.84,1.16) 0.99 (0.83,1.18)
Most 0.82 (0.73,0.93) 0.82 (0.72,0.94) 0.85 (0.70,1.05)
p = 0.011 p =< 0.001 p = 0.10
Population density category (people per sq km)
-250 Not in model 1.00 Not in model 1.00 1.00
-1000 0.91 (0.80,1.03) 0.99 (0.84,1.16) 0.99 (0.83,1.17)
-2500 0.99 (0.88,1.11) 1.08 (0.93,1.26) 1.10 (0.94,1.30)
>2500 1.04 (0.91,1.19) 1.13 (0.96,1.32) 1.14 (0.95,1.36)
p = 0.30 p = 0.36 p = 0.27
Individual socioeconomic position4





1. P-values for contribution of whole factor to the model; modified Wald test. Generalised estimating equations based on Poisson regression with 
robust standard errors calculated at the practice level. Models all factors shown. 2. Individual socioeconomic information was only available in a 
subset of the practices because of the nature of the interventions 3. There was one record per person per year of eligibility for inclusion in the 
vaccination analysis 4. A = owner occupier with central heating. B = three categories combined because very similar in uptake: owner-occupier 
without central heating, renter with central heating, renter without central heating; C = supported housing
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The study has limitations. To increase the size of the study,
the analysis presented included everyone in the practices
with records in a given year; this means that the year-on-
year figures reflect not only real change in uptake for indi-
viduals but also any substantial change in composition of
the samples from year to year. It is therefore reassuring
both that sample composition was similar from year to
year (Tables 2, 3) and that confining results to those with
information for all four years produced similar results. We
did not consider it sufficient to use the subsample with
records for all four years, in case they were a select group
whose survival in the practice was the result of better
health, and a greater tendency to take prophylactic action.
However, their uptake of vaccination in 1997 was no
higher than the fuller sample in 1997. A separate paper
evaluating a wider range of factors at practice and individ-
ual level associated with uptake in 2000 is in preparation.
The socioeconomic information refers to that pertaining
at the time of assessment. There may be misclassification
in later years, if people have moved into sheltered or insti-
tutional accommodation where vaccination is encour-
aged. However, if this was distorting the results, one
would expect the tenure differential to be weaker the more
time had elapsed since assessment but this was not found.
Conclusions
Substantial scope for improvement remains but the
upturn in 2000 should encourage efforts to increase vac-
cine uptake further. Socioeconomic variation was less
substantial than the authors expected but, in keeping with
government policy, we recommend periodic assessment
of, and response to, socio-economic differentials in access
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